SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?


To: StockMiser who wrote (331)11/3/1999 6:23:00 PM
From: Dr. Seuss  Read Replies (1) | Respond to of 566
 
After years of research and setbacks, Cell Pathways is waiting for FDA approval of its new cancer drug.

And that's the title of the final chapter of this story...except for the answer from the FDA. We'll just have to wait for that.

Dr.



To: StockMiser who wrote (331)11/10/1999 11:23:00 AM
From: tuck  Read Replies (2) | Respond to of 566
 
SM or anybody,

We're up big on high volume and no news yet. Any ideas?

Cheers, Tuck